Results 141 to 150 of about 56,782 (308)

Biliary Tract Excretion of Cefazolin, Cephalothin, and Cephaloridine in the Presence of Biliary Tract Disease

, 1974
Kenneth R. Ratzan, Carlos J. Ceacero, George L. Irvin   +2 more
openalex   +2 more sources

Organ‐sparing strategies in patients with MSI/dMMR tumors including Lynch syndrome: Current state of the art and future perspectives for clinical decision‐making

International Journal of Cancer, EarlyView.
Abstract Deficiency in DNA mismatch repair (dMMR) is a common pathway of carcinogenesis across different tumor types and confers a characteristic microsatellite instability‐high (MSI‐H) molecular phenotype. The MSI‐H/dMMR phenotype may arise from an inherited pathogenic variant in the context of Lynch syndrome and is most frequently observed in ...
Martin Duval, Antoine Dardenne, Thomas Samaille, Leo Mas, Jérémie H. Lefèvre, Xavier Dray, Mathilde Wagner, Romain Cohen, Thierry André   +8 more
wiley   +1 more source

Increased attention should be given to frozen section analysis during re-operation for incidental gallbladder carcinoma

Asian Journal of Surgery
Junke Wang, Min Gao, Fuyu Li
doaj   +1 more source

Current status of peroral cholangioscopy in biliary tract diseases. [PDF]

World J Gastrointest Endosc, 2015
Ghersi S, Fuccio L, Bassi M, Fabbri C, Cennamo V.   +4 more
europepmc   +1 more source

Ursodeoxycholic acid-enhanced efficiency and safety of statin therapy in patients with liver, gallbladder, and/or biliary tract diseases: The RACURS study

, 2014
С. Ю. Марцевич, Н. П. Кутишенко, L. Yu. Drozdova, О. В. Лерман, В. А. Невзорова, Ilya Reznik, Г. В. Шавкута, Д. А. Яхонтов   +7 more
openalex   +1 more source

Constant painful point in diseases of the liver and biliary tract. Sabatini (after ref. F. Chir., 1926, no. 1)

, 2021
M. Friedland
openalex   +1 more source

Beyond a Conduit: The Evolution of Functional Biliary Stents From Active Intervention to Enabling Platforms

iNew Medicine, EarlyView.
This review traces the evolution of functional biliary stents, outlining the paradigm shift from “active intervention” strategies that target stent failure to next‐generation “enabling platforms.” These platforms leverage biodegradable materials, 3D/4D printing, and smart sensors to achieve personalized, regenerative, and theranostic solutions ...
Muhan Li, Xu Liu, Xin Ye, Zhixia Dong, Xinjian Wan   +4 more
wiley   +1 more source

Global, regional, and national burden of gallbladder and biliary tract diseases: A systematic analysis of prevalence, incidence, deaths, and disability-adjusted life years with projections to 2050. [PDF]

Ann Hepatobiliary Pancreat Surg
Zheng Y, Duan Y, He X, Luo H, Zheng X.
europepmc   +1 more source

Diagnosis and Management of Diseases of the Biliary Tract [PDF]

, 1940

openalex   +1 more source

Inflammatory bowel disease and metabolic reprogramming: From pathological mechanisms to targeted interventions

Interdisciplinary Medicine, EarlyView.
This review explores the role of metabolic reprogramming in inflammatory bowel disease (IBD) by focusing on immune and epithelial cell metabolism, microbial metabolites, and their impact on inflammation. It discusses emerging metabolic therapies and emphasizes the importance of personalized microbiota‐targeted approaches to improve clinical outcomes in
Zemin Tian, Yinde Huang, Ying Wang, Chenyu Zhao, Zhaokai Zhou, Hua Yang, Yuan Qiu   +6 more
wiley   +1 more source